CSIMarket Company Name, Ticker, Suppliers, else..
 
Gritstone Bio Inc   (NASDAQ: GRTS)
 

GRTS's Market share relative to its competitors, as of Q2 2024

As of Q2 2024 (Revenue in Millions of $)

Date modified: 2026-07-31T07:21:29+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2024		 MARKET SHARE
12 Months
Q2 2024		 MARKET SHARE
MRQ
Q2 2024		 MARKET SHARE
A Quarter Before
Q1 2024
Gritstone Bio Inc 14.61 0.07% 0.02 % 0.02 %
Ayala Pharmaceuticals Inc 3.74 0.02% 0.00% 0.00%
Bellicum Pharmaceuticals Inc 1.52 0.01% 0.02% 0.00%
Crispr Therapeutics Ag 25.17 0.13% 0.31% 0.14%
Editas Medicine Inc 47.01 0.23% 0.29% 0.04%
Elicio Therapeutics Inc 29.70 0.15% 0.00% 0.00%
32 more competitors available

Sign in to see all competitors for Gritstone Bio Inc .

Sign In Create Free Account



GRTS's Market share relative to its competitors, as of Q2 2024 within the Biotechnology & Pharmaceuticals Industry
As of Q2 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2024		 MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
MRQ
Q2 2024		 MARKET SHARE

Q1 2024
Gritstone Bio Inc 0.21% 0.23% 0.07 % 0.05 %
Crispr Therapeutics Ag 0.37% 0.05% 0.90% 0.28%
Editas Medicine Inc 0.68% 0.60% 0.84% 0.08%
Immunitybio inc 2.41% 1.66% 3.63% 1.22%
Moderna Inc 32.32% 28.55% 10.26% 10.71%
Biontech Se 47.06% 45.25% 47.06% 81.92%
25 more companies available

Sign in to see all industry competitors for Gritstone Bio Inc .

Sign In Create Free Account



GRTS's Market share relative to its competitors, as of Q2 2024 within the Healthcare Sector
As of Q2 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2024		 MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
MRQ
Q2 2024		 MARKET SHARE

Q1 2024
Gritstone Bio Inc 0.19% 0.23% 0.06 % 0.05 %
Ayala Pharmaceuticals Inc 0.05% 0.05% 0.00% 0.00%
Bellicum Pharmaceuticals Inc 0.02% 0.02% 0.06% 0.00%
Crispr Therapeutics Ag 0.33% 0.05% 0.81% 0.28%
Editas Medicine Inc 0.63% 0.59% 0.76% 0.08%
Elicio Therapeutics Inc 0.40% 0.43% 0.00% 0.00%
31 more companies available

Sign in to see all sector competitors for Gritstone Bio Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Gritstone Bio Inc's market divisions, geographic dispersion, segments, products, and services, visit Gritstone Bio Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.